ANI PHARMACEUTICALS INC — Director's Dealing 2019

Apr 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-04-06

Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-06	Common Stock	F	3282	$70.50	Disposed	236396	Direct
2019-04-07	Common Stock	F	2115	$70.50	Disposed	234281	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,275 shares of restricted stock, which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,688 shares of restricted stock, which was previously reported.